Position in DNLI
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$217,668
-$306,722 QoQ
Shares Held
8,463
-73.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#193
of 290 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PSP Research LLC holds $24,943,899 across 66 Biotechnology names. DNLI ranks #58 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,000 | $616,770 | |
| 2 | NRIX |
Nurix Therapeutics, Inc.
|
25,000 | $606,500 | |
| 3 | INCY |
Incyte Corp
|
5,300 | $600,808 | |
| 4 | ARGX |
Argenx SE
|
641 | $594,700 | |
| 5 | IRON |
Disc Medicine, Inc.
|
8,000 | $585,120 | |
| 6 | RAPP |
Rapport Therapeutics, Inc.
|
14,000 | $583,380 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
17,000 | $567,630 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
30,000 | $559,500 |
All Filings in DNLI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,668 | 8,463 | Shares | Sole | 2026-07-09 | |
| 2025-12-31 | $524,390 | 31,762 | Shares | Sole | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||